Respiratory News: Breaking Respiratory News, Comments and Articles. - Page: 2

15:08 EDT 27th March 2015 | BioPortfolio

Respiratory News - Page: 2Twitter RSS

Read the latest Respiratory News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Respiratory.

Search or Follow Our Respiratory - Page: 2 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Respiratory - Page: 2 News.
You can also follow our Respiratory - Page: 2 news stories on Twitter: @Respiratory_Bio

Showing "respiratory airways lungs breath" News Articles 26 to 50 of 2,600+

Wednesday 25th March 2015

A metabolic imbalance increases the risk of respiratory diseases in childhood

(Helmholtz Centre for Environmental Research - UFZ) An imbalance in our metabolism can trigger inflammatory processes in the body and activate the immune system. In a recent study, published in the Journal of Allergy and Clinical Immunology, UFZ res...

A human respiratory tissue model to assess the toxicity of inhaled chemicals and pollutants

(R&D at British American Tobacco) A 3-dimensional model of human respiratory tissue has been shown to be an effective platform for measuring the impact of chemicals, like those found in cigarette smoke, or other aerosols on the lung. The researchers...

Study Demonstrates Concern for Retained Blood Syndrome after Heart Surgery; ClearFlow Executives Comment on New Data

Cardiac anesthesia investigators from Germany presented data this week at the International Anesthesia Research Society’s (IARS) 2015 Annual Meeting and International Science Symposium in Honolulu, HI. Critical care specialists from Charité - Universitätsmedizin Berlin’s Department of Anesthesiology and Intensive Care Medicine presented clinical data...

Common Bacteria on the Verge of Becoming Antibiotic-Resistant Superbugs

Antibiotic resistance is poised to spread globally among bacteria frequently implicated in respiratory and urinary infections in hospital settings, according to new research at Washington University School of Medicine in St. Louis. The study shows that two genes that confer resistance against a particularly strong class of antibiotics can be

Schroth Method Expert Offers Advice about Nonsurgical Scoliosis Treatment

Misinformation exists about the conservative treatment of adolescent idiopathic scoliosis. U.S. Schroth Method Expert Dr. Marc Moramarco sets the record straight and offers advice to parents of adolescents with scoliosis. Boston, MA (PRWEB) March 25, 2015 At a juncture where increasing numbers of patients and parents are choosing conservative treatment for adolescent idiopathic scoliosis (AIS), m...

Ancon Medical Researchers Make Nanotechnology Breakthrough for Disease Screening Technology

Ancon Medical Nanoparticle Biomarker Tagging (NBT) Device Can Already Detect Many Disease Biomarkers BLOOMINGTON, MN (PRWEB) March 25, 2015 Researchers at Ancon Medical Inc. have made a breakthrough in nanoparticle technology that will enable broader and less invasive screening for cancer, tuberculosis and many other diseases with a simple breath screen. The Minnesota-based medical device maker w...

Mauna Kea Technologies Announces Publication of Confirmation Data on the Value of Endomicroscopy for the Characterization of Pancreatic Cystic Neoplasms

PARIS, March 25, 2015 /PRNewswire/ --    Investigator-Initiated DETECT Study shows benefits of using Cellvizio to safely differentiate the nature of pancreas cysts with high specificity and accuracy  Findings from research team at UC Irvine published in peer-reviewed journal "Gastrointestinal Endoscopy"  Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cel...

New insights into little known but common birth defect: Congenital diaphragmatic hernia

Congenital diaphragmatic hernia (CDH) is not as well known as muscular dystrophy and cystic fibrosis, but like them it is a life-threatening birth defect, and is just as common. Occurring in one in 3,000 births, CDH causes the guts and liver to protr...

Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis

Data from Evidence of Effect Trial Provide Support for Novel Mechanism of Action in Neuromuscular Diseases South San Francisco, CA, March 25, 2015 - Cytokinetics, Incorporated (Nasdaq: CYTK) announced the publication of a manuscript relating to its fast skeletal muscle troponin activator tirasemtiv in the journal Neurotherapeutics.  This publication summarizes results from a Ph...

Justices to Hear Arguments Over EPA Mercury Limits

WASHINGTON (AP) — The Supreme Court is taking up a challenge by industry groups and Republican-led states that want to roll back Obama administration environmental rules aimed at reducing power plant emissions of mercury and other hazardous air pol...

Experience saves lives: Advanced life-support study reveals differences in survival rates

An advanced form of life support that takes over for the failing hearts and lungs of critically ill patients saves lives. But for adults, the odds of surviving depend on which hospital provides the life-supporting treatment - with the best odds at on...

Growing 3D miniature lungs from stem cells

Chuck Bednar for redOrbit.com - @BednarChuck Researchers from the University of Michigan have cooked-up the perfect recipe for growing miniature, three-dimensional human lungs from stem cells, but you won’t find this recipe in a cookbook – it appears in the latest edition of the journal eLife. Lead author Dr. Jason Spence, a professor at the UM Medical School in Ann Arbor, and colleagues fro...

Mucosis to Present on Intranasal Respiratory Syncytial Virus Vaccine Candidate SynGEM® at BioCapital Europe

Groningen, the Netherlands, March 25, 2015 – Mucosis B.V., a clinical stage biotechnology company using a proprietary technology platform to develop next-generation needle-free human vaccines for infectious diseases, announces today that CEO, Tom Johnston, will present a Company update at BioCapital Europe in Amsterdam on March 26. During the conference, Mucosis will present an update on...

European Sleep Apnea Devices Market, by Segment (Sleep Apnea Diagnostic Devices (Home Sleep Testing, Respiratory Polygraphs, Actigraphy Systems) and Sleep Apnea Therapeutic Devices (Pap Devices, Oxygen Devices, Airway Clearance Systems)-Forecast to 2019

Recently added to the BioPortfolio report store, European Sleep Apnea Devices Market, by Segment (Sleep Apnea Diagnostic Devices (Home Sleep Testing, Respiratory Polygraphs, Actigraphy Systems) and Sleep Apnea Therapeutic Devices (Pap Devices, Oxygen Devices, Airway Clearance Systems)-Forecast to 2019 is a new report from Micro Market Monitor published on 2015-02-01. This 144-page report is avail...

Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019

Recently added to the BioPortfolio report store, Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019 is a new report from Micro Market Monitor published on 2015-02-16. This 144-page report is available in PDF from $4250. The global sleep apnea devices market is expected to grow at a CAGR of 16.6% during the forecast p...

North American Sleep apnea devices Market by Types (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Forecast to 2019

Recently added to the BioPortfolio report store, North American Sleep apnea devices Market by Types (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Forecast to 2019 is a new report from Micro Market Monitor published on 2015-02-09. This 153-page report is available in PDF from $2650. The North American sleep apnea devices market is estimated to grow at a CAGR of 15.9% from 20...

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H1 2015

Recently added to the BioPortfolio report store, Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-02-23. This 62-page report is available in PDF from $2000. Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Severe Acut...

Egalet Provides Commercial Update on SPRIX® and OXAYDO™

WAYNE, Pa., March 25, 2015 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced its plans for the commercialization of SPRIX (ketorolac tromethamine) Nasal Spray and OXAYDO (oxycodone HCI, USP) tablets for oral use only –CII. SPRIX is a n...

Tuesday 24th March 2015

Pieris Pharmaceuticals Reports Full-Year 2014 Financial Results and Provides Corporate Update

FREISING, GERMANY--(Marketwired - March 25, 2015) - Pieris Pharmaceuticals, Inc. (OTCQB: PIRS) (the "Company" or "Pieris"), a biotechnology company advancing its patented and proprietary Anticalin® biotherapeutic technologies, reported today 2014 corporate highlights, a clinical development overview, and financial results for the year ending December 31, 2014. "I'm pleased to report that 2014 w...

Tracing the spread of drug-resistant TB

An international research team has, for the first time, used DNA sequencing to trace the fatal spread of multidrug-resistant tuberculosis (MDR-TB) between patients in the UK. Their study has been published in the journal Emerging Infectious Diseases. TB is spread by inhaling tiny airborne droplets from an infected person, with its bacteria able to survive in the lungs for long periods without cau...

Common bacteria on verge of becoming antibiotic-resistant superbugs

(Washington University School of Medicine) Antibiotic resistance is poised to spread globally among bacteria frequently implicated in respiratory and urinary infections in hospital settings, according to new research at Washington University School o...

Pediatric Medicines: Global Markets

LONDON, March 24, 2015 /PRNewswire/ -- REPORT HIGHLIGHTSThe global market for pediatric medicines reached $80.7 billion in 2013 and should reach $83.6 billion in 2014. This market is expected to reach about $100.7 billion by 2019, registering a compound annual growth rate (CAGR) of 3.8% from 2014 to 2019.This report provides:An overview of the global market for pediatric medicines.Analyses of glob...

Product and Pipeline Analysis of the Global Vaccines Market : Expected Launches in the Areas of Cancer and Allergies Will Drive Growth

LONDON, March 24, 2015 /PRNewswire/ -- Executive Summary•Vaccines are a class of biologics administered to prevent infectious diseases and reduce mortality and morbidity. It is estimated that vaccines have reduced the incidence of some diseases by more than xx%.•Vaccines are now available for prevention of about xx infectious diseases.•Coupled with powerful techniques such as pol...

Incidence of Anaphylaxis During Winter Events Highlights Importance of Adding a Preparedness Checklist to Holiday Planning

BASKING RIDGE, N.J., Dec. 18, 2012  /PRNewswire/ -- Findings from an online survey released today by Mylan Specialty L.P., the fully-integrated specialty pharmaceutical business of Mylan Inc. (Nasdaq: MYL), reveal that, of those surveyed, more than half (55%) of children with life-threatening allergies have experienced anaphylaxis (a life-threatening allergic reaction) during a winte...

Dey Pharma to Offer EpiPen 2-Pak® and EpiPen Jr 2-Pak® Exclusively

BASKING RIDGE, N.J., Aug. 24, 2011 /PRNewswire/ -- Dey Pharma, L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL), today announced that Dey will exclusively offer the EpiPen 2-Pak® and EpiPen Jr 2-Pak® (epinephrine) Auto-Injector 0.3/0.15 mg, to encourage physicians and patients to follow recommendations by the National Institute of Allergy and Infectious Diseases (NIAID). While there is no s...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks